Wuxi Bio to Sell Vaccine Facility to Merck

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).
Merck (MRK) ended the recent trading session at $99.72, demonstrating a +0.59% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.55%.
Merck, a leading science and technology company, announced the closing of the transaction to acquire HUB Organoids Holding ...
Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at ...